–
Статьи в журналах
-
- 2023 Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
- Herbst Roy S., Wu Yi-Long, John Thomas, Grohe Christian, Majem Margarita, Wang Jie, Kato Terufumi, Goldman Jonathan W., Laktionov Konstantin
- в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 41, № 8 DOI